AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Grikli-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Prector Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Grikli-M1 Tablet SR

DiaBeta-Duo SR tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. DiaBeta-Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a readily available fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Pregnancy or breastfeeding necessitates physician consultation. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be advised by your doctor.

Uses of Grikli-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Grikli-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Grikli-M1 SR Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Grikli-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Grikli-M1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Grikli-M1 SR Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Grikli-M1 Tablet SR works:

Grikli-M1 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Grikli-M1 SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Grikli-M1 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Grikli-M1 tablets are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Grikli-M1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Grikli-M1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Grikli-M1 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, Grikli-M1 Tablet SR is contraindicated in those with severe liver disease.

What if you forget to take Grikli-M1 Tablet SR :

Should you forget to take a Grikli-M1 Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Grikli-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Grikli-M1 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Grikli-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Grikli-M1 Tablet SR and seek immediate medical attention.
Grikli-M1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Grikli-M1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Grikli-M1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Grikli-M1 Tablet SR can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Grikli-M1 Tablet SR and alcohol is unsafe. Alcohol may worsen Grikli-M1's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Grikli-M1 Tablet SR
51
MRP 62
17% off